Form 4: Hillenbrand Interim CFO Reports Acquisition of Additional Restricted Stock Units

Sentiment:

Insider Transaction Report


Megan A. Walke, Interim CFO of Hillenbrand, Inc., reported changes in her beneficial ownership, including the acquisition of additional restricted stock units.

Summary

  • Megan A. Walke, serving as Interim CFO, VP, CC, and CAO of Hillenbrand, Inc. (HI), filed a Statement of Changes in Beneficial Ownership.
  • As of June 30, 2025, Megan A. Walke directly beneficially owns 4,966 shares of Hillenbrand, Inc. Common Stock.
  • On June 30, 2025, she acquired additional Restricted Stock Units (RSUs) as part of deferred stock awards.
  • This includes 6 RSUs from a December 7, 2022 award, bringing the total for that award to 570 RSUs.
  • An additional 20 RSUs were acquired from a December 7, 2023 award, resulting in a total of 1,813 RSUs for that award.
  • Furthermore, 37 RSUs were acquired from a December 5, 2024 award, increasing that total to 3,342 RSUs.
  • Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock and is entitled to dividend equivalent rights.
  • The RSUs have staggered vesting schedules: the 2022 award vests one-third on December 7, 2023, December 7, 2024, and December 7, 2025; the 2023 award vests one-third on December 7, 2024, December 7, 2025, and December 7, 2026; and the 2024 award vests one-third on December 5, 2025, December 5, 2026, and December 5, 2027.

Sentiment

Score: 7

Explanation: The filing indicates routine executive compensation activity, specifically the acquisition of additional Restricted Stock Units, which generally aligns executive interests with long-term company performance. This is a neutral to slightly positive signal as it shows continued executive commitment through equity incentives.

Positives

  • The acquisition of additional Restricted Stock Units by a key executive like the Interim CFO indicates continued alignment of management's interests with long-term shareholder value.
  • The use of deferred stock awards and RSU grants is a standard practice in executive compensation, serving as a retention mechanism and incentivizing sustained performance.

Future Outlook

The vesting schedules for the Restricted Stock Units extend through December 2027, indicating a long-term incentive structure for the Interim CFO and a continued alignment of her interests with the company's future performance.

Industry Context

This Form 4 filing reflects standard executive compensation practices within publicly traded companies, where equity awards like Restricted Stock Units are commonly used to align executive incentives with long-term shareholder value creation. Such filings are routine disclosures for insider transactions and provide transparency into executive holdings.

Comparison to Industry Standards

  • The use of Restricted Stock Units with multi-year, staggered vesting schedules is a common and widely accepted practice in executive compensation across various industries, including manufacturing and industrial companies similar to Hillenbrand.
  • This structure is designed to promote long-term retention of key executives and align their performance incentives with the company's sustained growth and profitability.
  • Comparable companies in the industrial manufacturing sector, such as Dover Corporation, Illinois Tool Works, or Parker-Hannifin Corporation, frequently utilize similar equity-based incentive plans for their senior executives to foster long-term commitment and performance.

Stakeholder Impact

  • Shareholders: The acquisition of additional equity by a key executive can be viewed positively as it aligns management's interests with shareholder value creation and long-term company performance.
  • Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

  • Future vesting dates for the Restricted Stock Units are scheduled for December 7, 2025, December 5, 2026, December 7, 2026, and December 5, 2027.
  • Subsequent Form 4 filings will be required for any further changes in beneficial ownership by the reporting person.

Key Dates

DateDescription
2022-12-07Date of initial Deferred Stock Award for 570 Restricted Stock Units.
2023-12-07First vesting date for Restricted Stock Units from the 2022 award; Date of initial Deferred Stock Award for 1,813 Restricted Stock Units.
2024-12-07Second vesting date for Restricted Stock Units from the 2022 award; First vesting date for Restricted Stock Units from the 2023 award.
2024-12-05Date of initial Deferred Stock Award for 3,342 Restricted Stock Units.
2025-06-30Date of earliest transaction reported, involving the acquisition of additional Restricted Stock Units.
2025-07-02Signature date of the reporting person's attorney-in-fact.
2025-12-05First vesting date for Restricted Stock Units from the 2024 award.
2025-12-07Third vesting date for Restricted Stock Units from the 2022 award; Second vesting date for Restricted Stock Units from the 2023 award.
2026-12-05Second vesting date for Restricted Stock Units from the 2024 award.
2026-12-07Third vesting date for Restricted Stock Units from the 2023 award.
2027-12-05Third vesting date for Restricted Stock Units from the 2024 award.

Keywords

Hillenbrand, HI, SEC Form 4, Beneficial Ownership, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Megan A. Walke, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.